Day: February 15, 2021
Scanfil Oyj:n tilinpäätöstiedotteen julkistaminen ja esittely verkossaSCANFIL OYJ SIJOITTAJAUUTINEN 15.2.2021 klo 10.00SCANFIL OYJ:N TILINPÄÄTÖSTIEDOTTEEN JULKISTAMINEN JA ESITTELY VERKOSSAScanfil Oyj julkistaa 1.1.-31.12.2020 tilinpäätöstiedotteen torstaina 18.2.2021 klo 08.00. Analyytikoilla, sijoittajilla ja tiedotusvälineillä on mahdollisuus seurata tilinpäätöstiedotteen esittelyä samana päivänä 18.2.2021 klo 10.00 alkaen verkossa. Tilaisuuteen voi osallistua https://scanfil.videosync.fi/2020-tulokset kautta.Tilinpäätöstiedotteen esittelee toimitusjohtaja Petteri Jokitalo. Analyytikot, sijoittajat ja tiedotusvälineet voivat lähettää ennakkoon tilinpäätöstiedotteeseen liittyviä kysymyksiä sähköpostiosoitteeseen minna.oksanen@scanfil.com 18.2.2021 klo 9.00 saakka. Tilaisuudessa on myös mahdollista laittaa kysymyksiä...
ArcelorMittal announces share buyback program
Written by Customer Service on . Posted in Public Companies.
15 February 2021, 08:00 CETArcelorMittal (‘the Company’) today announces a share buyback program (the ‘Program’) under the authorization given by the annual general meeting of shareholders held on June 13, 2020 (the ‘AGM Authorization’).For the background to this Program, reference is made to the Company’s press release dated 9 February relating to the Company selling 40 million Cleveland-Cliffs common shares for gross proceeds of US$652 million.The shares acquired under the Program are intended:1) To meet ArcelorMittal’s obligations under debt obligations exchangeable into equity securities, and/or;2) To reduce its share capital.ArcelorMittal intends to repurchase shares for an aggregate maximum amount of US$650 million in accordance with the AGM Authorization and applicable market abuse regulations. The Program will commence today1.Furthermore,...
UTI GROUP : CHIFFRE D’AFFAIRES ANNUEL 2020 : 18,02 M€
Written by Customer Service on . Posted in Public Companies.
Communiqué de presse Paris le 15 février 2021Chiffre d’affaires annuel 2020 : 18,02 M€UTI GROUP, Entreprise de Services du Numérique (ESN) dédiée au conseil et à l’intégration des nouvelles technologies au sein des grandes entreprises, publie son chiffre d’affaires annuel consolidé au 31 décembre 2020 permettant de faire ressortir les éléments comparatifs suivants : Selon l’information sectorielle retenue dans les comptes consolidés, le chiffre d’affaires consolidé se décompose ainsi :(*) : Non AuditésA l’issue de l’exercice 2020, UTI GROUP enregistre un chiffre d’affaires consolidé de 18,02 M€, en retrait de 23,3 % par rapport au chiffre d’affaires de l’exercice 2019. Cette baisse résulte principalement du ralentissement de...
ArcelorMittal announces share buyback program
Written by Customer Service on . Posted in Public Companies.
15 February 2021, 08:00 CETArcelorMittal (‘the Company’) today announces a share buyback program (the ‘Program’) under the authorization given by the annual general meeting of shareholders held on June 13, 2020 (the ‘AGM Authorization’).For the background to this Program, reference is made to the Company’s press release dated 9 February relating to the Company selling 40 million Cleveland-Cliffs common shares for gross proceeds of US$652 million.The shares acquired under the Program are intended:1) To meet ArcelorMittal’s obligations under debt obligations exchangeable into equity securities, and/or;2) To reduce its share capital.ArcelorMittal intends to repurchase shares for an aggregate maximum amount of US$650 million in accordance with the AGM Authorization and applicable market abuse regulations. The Program will commence today1.Furthermore,...
Synairgen announces that dosing has commenced with its inhaled interferon beta product in US Government-funded NIH ACTIV-2 trial in COVID-19 outpatients
Written by Customer Service on . Posted in Public Companies.
Press releaseSynairgen plc(‘Synairgen’ or the ‘Company’) Synairgen announces that dosing has commenced with its inhaled interferon beta product in US Government-funded NIH ACTIV-2 trial in COVID-19 outpatientsSouthampton, UK – 15 February 2021: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, today announces that dosing has begun in the inhaled interferon beta formulation (SNG001) sub-study of the ACTIV-2 Phase II/III trial, evaluating patients with mild to moderate COVID-19 symptoms not yet requiring hospitalisation.Richard Marsden, CEO of Synairgen, said: “We are delighted that our inhaled interferon beta formulation has been entered into this US Government-funded Phase II/III study and that dosing has now commenced. With mutations of COVID-19 now emerging, and...
UTI GROUP : CHIFFRE D’AFFAIRES ANNUEL 2020 : 18,02 M€
Written by Customer Service on . Posted in Public Companies.
Communiqué de presse Paris le 15 février 2021Chiffre d’affaires annuel 2020 : 18,02 M€UTI GROUP, Entreprise de Services du Numérique (ESN) dédiée au conseil et à l’intégration des nouvelles technologies au sein des grandes entreprises, publie son chiffre d’affaires annuel consolidé au 31 décembre 2020 permettant de faire ressortir les éléments comparatifs suivants : Selon l’information sectorielle retenue dans les comptes consolidés, le chiffre d’affaires consolidé se décompose ainsi :(*) : Non AuditésA l’issue de l’exercice 2020, UTI GROUP enregistre un chiffre d’affaires consolidé de 18,02 M€, en retrait de 23,3 % par rapport au chiffre d’affaires de l’exercice 2019. Cette baisse résulte principalement du ralentissement de...
Synairgen announces that dosing has commenced with its inhaled interferon beta product in US Government-funded NIH ACTIV-2 trial in COVID-19 outpatients
Written by Customer Service on . Posted in Public Companies.
Press releaseSynairgen plc(‘Synairgen’ or the ‘Company’) Synairgen announces that dosing has commenced with its inhaled interferon beta product in US Government-funded NIH ACTIV-2 trial in COVID-19 outpatientsSouthampton, UK – 15 February 2021: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, today announces that dosing has begun in the inhaled interferon beta formulation (SNG001) sub-study of the ACTIV-2 Phase II/III trial, evaluating patients with mild to moderate COVID-19 symptoms not yet requiring hospitalisation.Richard Marsden, CEO of Synairgen, said: “We are delighted that our inhaled interferon beta formulation has been entered into this US Government-funded Phase II/III study and that dosing has now commenced. With mutations of COVID-19 now emerging, and...
WESTPAY APPOINTS ABG SUNDAL COLLIER AS LIQUIDITY PROVIDER
Written by Customer Service on . Posted in Public Companies.
Westpay AB, a leading fintech company, has entered into an agreement with ABG Sundal Collier ASA that they will act as a liquidity provider for Westpay’s share.The commitment takes place within the framework of Nasdaq Stockholm AB’s rules on liquidity enhancement and means that the liquidity provider quotas the purchase and sale volume corresponding to at least SEK 15,000 with a spread of a maximum of 4% between the buy and sell price. The purpose is to promote the share’s liquidity and the commitment will begin on February 15, 2021.For additional information, please contact:Sten Karlsson, CEO Westpay ABMobile: +46 70-555 6065Email: sten.karlsson@westpay.seLars Levin, CFO Westpay ABMobile: +46 70-8966 404Email: lars.levin@westpay.seWestpay’s Certified Adviser is Erik Penser Bank,phone: +46 8-463 80 00, email: certifiedadviser@penser.se AttachmentPressrelease_20210215_Westpay...
Real People Investment Holdings Limited: Financial Results – Third Quarter 2021
Written by Customer Service on . Posted in Public Companies.
Real People Investment Holdings Limited has released its third quarter 2021 earnings on www.realpeoplegroup.co.za.Attachment12. RPIH Q3 Results – December 2020 Website
WESTPAY APPOINTS ABG SUNDAL COLLIER AS LIQUIDITY PROVIDER
Written by Customer Service on . Posted in Public Companies.
Westpay AB, a leading fintech company, has entered into an agreement with ABG Sundal Collier ASA that they will act as a liquidity provider for Westpay’s share.The commitment takes place within the framework of Nasdaq Stockholm AB’s rules on liquidity enhancement and means that the liquidity provider quotas the purchase and sale volume corresponding to at least SEK 15,000 with a spread of a maximum of 4% between the buy and sell price. The purpose is to promote the share’s liquidity and the commitment will begin on February 15, 2021.For additional information, please contact:Sten Karlsson, CEO Westpay ABMobile: +46 70-555 6065Email: sten.karlsson@westpay.seLars Levin, CFO Westpay ABMobile: +46 70-8966 404Email: lars.levin@westpay.seWestpay’s Certified Adviser is Erik Penser Bank,phone: +46 8-463 80 00, email: certifiedadviser@penser.se AttachmentPressrelease_20210215_Westpay...